rs11948853 - PRELID2
Magnitude 2.2 · 1 study on file
Reported associations
-
A reference map of potential determinants for the human serum metabolome. - Nature (2021) · Bar N, Korem T, Weissbrod O, Zeevi D, Rothschild D, Leviatan S, Kosower N, Lotan-Pompan M, Weinberger A, Le Roy CI, Menni C, Visconti A, Falchi M, Spector TD, Adamski J, Franks PW, Pedersen O, Segal E · PubMed 33177712
The serum metabolome contains a plethora of biomarkers and causative agents of various diseases, some of which are endogenously produced and some that have been taken up from the environment . The origins of specific compounds are known, including metabolites that are highly heritable , or those that are influenced by the gut microbiome , by lifestyle choices such as smoking , or by diet . However, the key determinants of most metabolites are still poorly understood. Here we measured the levels of 1,251 metabolites in serum samples from a unique and deeply phenotyped healthy human cohort of 491 individuals. We applied machine-learning algorithms to predict metabolite levels in held-out individuals on the basis of host genetics, gut microbiome, clinical parameters, diet, lifestyle and anthr
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
valsartan dosing based on PRELID2 genetic variation Moderate
PRELID2 variant rs11948853 is associated with altered valsartan plasma levels, affecting drug efficacy and side effect risk.
If taking valsartan, discuss genetic-based dosing adjustment with your physician or pharmacist.